ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Organic Eyebright Aerial Parts

Also known as: Eyebright, Euphrasia, Euphrasia officinalis

Overview

Organic Eyebright aerial parts are derived from the above-ground sections (leaves, stems, flowers) of *Euphrasia officinalis*, a small flowering plant historically utilized in European folk medicine for various eye-related conditions. Traditionally, it has been employed to address ailments such as conjunctivitis, blepharitis, eye inflammation, and general irritation. The plant is rich in bioactive phytochemicals, including phenolic compounds, flavonoids, and tannins, which contribute to its observed antioxidant, anti-inflammatory, and antimicrobial properties. Emerging research also explores its potential neuroprotective effects. While its traditional use is extensive, the scientific evidence supporting its efficacy is moderate, primarily consisting of preclinical studies and a limited number of small-scale human trials, with a notable absence of high-quality randomized controlled trials.

Benefits

Eyebright offers several potential benefits, primarily centered around eye health. Preliminary human studies suggest that eyebright extracts may alleviate eye inflammation and irritation. For instance, one uncontrolled study involving eye drops containing eyebright and rose extracts reported complete relief of redness, swelling, and burning in 81% of participants within 6–14 days, though eyebright's isolated effect and the lack of a control group limit the strength of this evidence. Furthermore, in vitro studies have demonstrated significant antioxidant capacity and antimicrobial activity of eyebright extracts against common eye pathogens like *Staphylococcus aureus* and *Pseudomonas aeruginosa*, suggesting a role in combating infections. Beyond ocular benefits, in vitro research indicates neuroprotective potential, with eyebright extracts improving cell viability by 17.5–22.6% in human neuroblastoma cells exposed to amyloid-beta peptides, hinting at a possible role in neurodegenerative disease prevention. Secondary, less-substantiated benefits include potential relief for respiratory symptoms such as sinusitis and allergies, attributed to its anti-inflammatory and astringent properties, though clinical evidence for these uses is very limited. The primary beneficiaries appear to be adults experiencing mild eye irritation or inflammation, with neuroprotective effects currently confined to preclinical models.

How it works

Eyebright's mechanism of action is primarily attributed to its rich phytochemical composition. Its antioxidant effects stem from phenolic compounds that scavenge free radicals, thereby reducing oxidative stress. The anti-inflammatory properties are likely mediated through the inhibition of pro-inflammatory mediators, though specific molecular targets are not fully elucidated. Antimicrobial activity may involve disrupting bacterial biofilms and inhibiting microbial growth, particularly against pathogens associated with eye infections. In the context of neuroprotection, eyebright extracts appear to reduce the toxicity induced by amyloid-beta peptides in neuronal cells, contributing to improved cell viability. When applied topically, eyebright interacts directly with ocular surface tissues to mitigate inflammation and combat microbial infections. Systemic bioavailability following oral intake is not well characterized, suggesting that its primary effects, especially for eye conditions, are localized.

Side effects

Eyebright is generally considered safe for short-term topical use or as a traditional tea/compress. Common side effects are rare but may include mild eye irritation or allergic reactions, particularly in sensitive individuals. There are no significant reports of uncommon or rare adverse effects in the available literature. While no well-documented drug interactions exist, caution is advised when using eyebright concurrently with other anti-inflammatory medications or ocular drugs, due to the potential for additive effects or unforeseen interactions. Contraindications include prolonged use without professional medical guidance, and it is not recommended for treating major eye diseases without proper medical supervision. The safety of eyebright in special populations such as pregnant or breastfeeding women, or children, has not been well established, and its use in these groups should be avoided or undertaken only under strict medical advice.

Dosage

The optimal and minimum effective dosages for eyebright are not well defined due to a lack of standardized clinical trials. Traditional use often involves topical application as compresses or eye drops, with concentrations typically unspecified. One preliminary human study utilized eye drops containing equal parts eyebright and rose extracts, applied three times daily for up to two weeks, showing symptom relief within 6–14 days. However, this study did not isolate eyebright's effects or establish a specific dosage. The maximum safe dose for eyebright has not been established, and prolonged use should be avoided without professional guidance. For eye conditions, topical application in the form of aqueous extracts or eye drops is preferred, as systemic absorption and bioavailability from oral intake are not well characterized. There are no identified cofactors required for eyebright's efficacy.

FAQs

Is eyebright effective for eye inflammation?

Preliminary evidence suggests potential benefits for mild eye inflammation, but more rigorous, well-controlled human trials are needed to confirm its efficacy.

Can eyebright treat major eye diseases?

There is no scientific evidence to support the use of eyebright for treating serious eye conditions such as cataracts, glaucoma, or macular degeneration.

Is it safe to use eyebright eye drops?

Eyebright eye drops are generally considered safe for short-term use, but it is advisable to consult a healthcare provider for prolonged use or if you have underlying eye conditions.

How quickly does eyebright work?

One preliminary study reported symptom relief for eye inflammation within 6–14 days when using eye drops containing eyebright and rose extracts.

Are there side effects from using eyebright?

Mild eye irritation or allergic reactions are possible but uncommon. Overall, eyebright is considered to have a good safety profile for short-term topical use.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC11244224/ – This in vitro study demonstrated that extracts from eyebright aerial parts possess significant antimicrobial activity against common eye pathogens, including *Staphylococcus aureus* and *Pseudomonas aeruginosa*, and can inhibit biofilm formation. It also confirmed the antioxidant properties of these extracts, providing mechanistic insights into eyebright's traditional uses for eye infections and inflammation.
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC11641456/ – This in vitro study investigated the neuroprotective potential of various eyebright extracts. It found that multiple extracts increased the viability of human neuroblastoma cells by 17.5–22.6% when exposed to amyloid-beta toxicity, suggesting a potential role for eyebright in mitigating neurodegenerative processes, though this is preclinical evidence.
  • https://www.healthline.com/nutrition/eyebright – This article references a human study where eye drops containing eyebright and rose extracts led to complete symptom relief in 81% of 65 participants with eye inflammation within 6–14 days. However, it notes the study's limitations, including its open-label, uncontrolled design, the use of a combined herbal preparation, and a small sample size, which reduces the strength of its clinical evidence.
  • https://www.medicinenet.com/eyebright_benefits_dosage_and_side_effects/article.htm – This source provides a general overview of eyebright's traditional benefits, dosage considerations, and potential side effects. It highlights its use for eye conditions and respiratory symptoms, while also emphasizing the lack of robust clinical trials to fully support many of its claimed benefits and establish standardized dosing or long-term safety.
  • https://www.webmd.com/vitamins/ai/ingredientmono-109/eyebright – WebMD's entry on eyebright discusses its traditional uses, primarily for eye conditions, and notes that there isn't enough reliable scientific evidence to support many of its purported benefits. It also touches upon safety concerns, particularly regarding the lack of data for pregnant/breastfeeding women and children, and advises caution with internal use.

Supplements Containing Organic Eyebright Aerial Parts

Woodstock Sinus Formula by Woodstock Herbal Products
65

Woodstock Sinus Formula

Woodstock Herbal Products

Score: 65/100